Current Progress in the Treatment of Metaplastic Breast Carcinoma
Authors:
- Wei-Xian ChenWCWei-Xian Chen
- Shan-Liang ZhongSZShan-Liang Zhong
- Jian LiJLJian Li
- Zhou LuoZLZhou Luo
- Jin-Hai TangJTJin-Hai Tang
- Jian-Hua ZhaoJZJian-Hua Zhao
Open Access
- 30 November 2013
- journal article
- review article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 14 (11) , 6221-6225
Abstract
Current Progress in the Treatment of Metaplastic Breast Carcinoma Metaplastic breast cancer;therapy;systematic review; Metaplastic breast cancer (MBC) is a rare type of breast carcinoma, characterized by various combinations of mesenchymal, adenocarcinoma and other epithelial components. MBC often manifests as a large mass, with low axillary lymph node involvement and poor prognosis. Knowledge and treatment patterns about MBC demographics, presentation and tumor characteristics are very limited. In clinical practice, MBC is usually treated based on the guidelines developed for infiltrating ductal carcinoma (IDC). The ideal treatment paradigm for MBC is unknown due to its low incidence and pathological variability, so potential predictors of treatment efficacy need to be explored. This review summarizes the current models and strategies for MBC according to the published literature.Keywords
This publication has 35 references indexed in Scilit:
- Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern eraBreast Cancer Research and Treatment, 2011
- The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patientsBreast Cancer Research and Treatment, 2011
- Triple-negative breast cancer: disease entity or title of convenience?Nature Reviews Clinical Oncology, 2010
- Basal-like breast carcinomas: clinical outcome and response to chemotherapyJournal of Clinical Pathology, 2006
- Metaplastic carcinoma of the breast Clinical presentation, treatment results and prognostic factorsActa Oncologica, 2006
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Metaplastic breast carcinoma: clinical–pathologic characteristics and HER2/neu expressionBreast Cancer Research and Treatment, 2005
- Targeting epidermal growth factor receptor—are we missing the mark?The Lancet, 2003
- Metaplastic carcinomas of the breastJournal of Surgical Oncology, 1999
- Spindle cell carcinoma of the breastHuman Pathology, 1984